Marco P Alves

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 11

Top Topics

Immune Response

Respiratory Syncytial Virus

Mesenchymal Stem Cells

Top Venues

Nature microbiology

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Jacob Schön, Güliz Tuba Barut, Bettina Salome Trueeb, Nico Joël Halwe, Inês Berenguer Veiga, Annika Kratzel, Lorenz Ulrich, Jenna N Kelly, Melanie Brügger, Christoph Langner, Adriano Taddeo, Etori Aguiar Moreira, Demeter Túrós, Llorenç Grau-Roma, Ann Kathrin Ahrens, Kore Schlottau, Tobias Britzke, Angele Breithaupt, Björn Corleis, Jana Kochmann, Blandina I Oliveira Esteves, Lea Almeida, Lisa Thomann, Christelle Devisme, Hanspeter Stalder, Silvio Steiner, Sarah Ochsenbein, Kimberly Schmied, Fabien Labroussaa, Joerg Jores, Philip V'kovski, Vladimir Cmiljanovic, Marco P Alves, Charaf Benarafa, Nadine Ebert, Donata Hoffmann, Martin Beer, Volker Thiel
A safe, effective and adaptable live-attenuated SARS-CoV-2 vaccine to reduce disease and transmission using one-to-stop genome modifications. Nature microbiology 9 (8) (2024)
Jacob Schön, Güliz Tuba Barut, Bettina Salome Trueeb, Nico Joël Halwe, Inês Berenguer Veiga, Annika Kratzel, Lorenz Ulrich, Jenna N Kelly, Melanie Brügger, Christoph Langner, Adriano Taddeo, Etori Aguiar Moreira, Demeter Túrós, Llorenç Grau-Roma, Ann Kathrin Ahrens, Kore Schlottau, Tobias Britzke, Angele Breithaupt, Björn Corleis, Jana Kochmann, Blandina I Oliveira Esteves, Lea Almeida, Lisa Thomann, Christelle Devisme, Hanspeter Stalder, Silvio Steiner, Sarah Ochsenbein, Kimberly Schmied, Fabien Labroussaa, Joerg Jores, Philip V'kovski, Vladimir Cmiljanovic, Marco P Alves, Charaf Benarafa, Nadine Ebert, Donata Hoffmann, Martin Beer, Volker Thiel
A safe, effective and adaptable live-attenuated SARS-CoV-2 vaccine to reduce disease and transmission using one-to-stop genome modifications. Nature microbiology 9 (8) (2024)
Jacob Schön, Güliz Tuba Barut, Bettina Salome Trueeb, Nico Joël Halwe, Inês Berenguer Veiga, Annika Kratzel, Lorenz Ulrich, Jenna N Kelly, Melanie Brügger, Christoph Langner, Adriano Taddeo, Etori Aguiar Moreira, Demeter Túrós, Llorenç Grau-Roma, Ann Kathrin Ahrens, Kore Schlottau, Tobias Britzke, Angele Breithaupt, Björn Corleis, Jana Kochmann, Blandina I Oliveira Esteves, Lea Almeida, Lisa Thomann, Christelle Devisme, Hanspeter Stalder, Silvio Steiner, Sarah Ochsenbein, Kimberly Schmied, Fabien Labroussaa, Joerg Jores, Philip V'kovski, Vladimir Cmiljanovic, Marco P Alves, Charaf Benarafa, Nadine Ebert, Donata Hoffmann, Martin Beer, Volker Thiel
A safe, effective and adaptable live-attenuated SARS-CoV-2 vaccine to reduce disease and transmission using one-to-stop genome modifications. Nature microbiology 9 (8) (2024)
Jacob Schön, Güliz Tuba Barut, Bettina Salome Trueeb, Nico Joël Halwe, Inês Berenguer Veiga, Annika Kratzel, Lorenz Ulrich, Jenna N Kelly, Melanie Brügger, Christoph Langner, Adriano Taddeo, Etori Aguiar Moreira, Demeter Túrós, Llorenç Grau-Roma, Ann Kathrin Ahrens, Kore Schlottau, Tobias Britzke, Angele Breithaupt, Björn Corleis, Jana Kochmann, Blandina I Oliveira Esteves, Lea Almeida, Lisa Thomann, Christelle Devisme, Hanspeter Stalder, Silvio Steiner, Sarah Ochsenbein, Kimberly Schmied, Fabien Labroussaa, Joerg Jores, Philip V'kovski, Vladimir Cmiljanovic, Marco P Alves, Charaf Benarafa, Nadine Ebert, Donata Hoffmann, Martin Beer, Volker Thiel
A safe, effective and adaptable live-attenuated SARS-CoV-2 vaccine to reduce disease and transmission using one-to-stop genome modifications. Nature microbiology 9 (8) (2024)
Jacob Schön, Güliz Tuba Barut, Bettina Salome Trueeb, Nico Joël Halwe, Inês Berenguer Veiga, Annika Kratzel, Lorenz Ulrich, Jenna N Kelly, Melanie Brügger, Christoph Langner, Adriano Taddeo, Etori Aguiar Moreira, Demeter Túrós, Llorenç Grau-Roma, Ann Kathrin Ahrens, Kore Schlottau, Tobias Britzke, Angele Breithaupt, Björn Corleis, Jana Kochmann, Blandina I Oliveira Esteves, Lea Almeida, Lisa Thomann, Christelle Devisme, Hanspeter Stalder, Silvio Steiner, Sarah Ochsenbein, Kimberly Schmied, Fabien Labroussaa, Joerg Jores, Philip V'kovski, Vladimir Cmiljanovic, Marco P Alves, Charaf Benarafa, Nadine Ebert, Donata Hoffmann, Martin Beer, Volker Thiel
A safe, effective and adaptable live-attenuated SARS-CoV-2 vaccine to reduce disease and transmission using one-to-stop genome modifications. Nature microbiology (2024)
Jacob Schön, Güliz Tuba Barut, Bettina Salome Trueeb, Nico Joël Halwe, Inês Berenguer Veiga, Annika Kratzel, Lorenz Ulrich, Jenna N Kelly, Melanie Brügger, Christoph Langner, Adriano Taddeo, Etori Aguiar Moreira, Demeter Túrós, Llorenç Grau-Roma, Ann Kathrin Ahrens, Kore Schlottau, Tobias Britzke, Angele Breithaupt, Björn Corleis, Jana Kochmann, Blandina I Oliveira Esteves, Lea Almeida, Lisa Thomann, Christelle Devisme, Hanspeter Stalder, Silvio Steiner, Sarah Ochsenbein, Kimberly Schmied, Fabien Labroussaa, Joerg Jores, Philip V'kovski, Vladimir Cmiljanovic, Marco P Alves, Charaf Benarafa, Nadine Ebert, Donata Hoffmann, Martin Beer, Volker Thiel
A safe, effective and adaptable live-attenuated SARS-CoV-2 vaccine to reduce disease and transmission using one-to-stop genome modifications. Nature microbiology (2024)
Jacob Schön, Güliz Tuba Barut, Bettina Salome Trueeb, Nico Joël Halwe, Inês Berenguer Veiga, Annika Kratzel, Lorenz Ulrich, Jenna N Kelly, Melanie Brügger, Christoph Langner, Adriano Taddeo, Etori Aguiar Moreira, Demeter Túrós, Llorenç Grau-Roma, Ann Kathrin Ahrens, Kore Schlottau, Tobias Britzke, Angele Breithaupt, Björn Corleis, Jana Kochmann, Blandina I Oliveira Esteves, Lea Almeida, Lisa Thomann, Christelle Devisme, Hanspeter Stalder, Silvio Steiner, Sarah Ochsenbein, Kimberly Schmied, Fabien Labroussaa, Joerg Jores, Philip V'kovski, Vladimir Cmiljanovic, Marco P Alves, Charaf Benarafa, Nadine Ebert, Donata Hoffmann, Martin Beer, Volker Thiel
A safe, effective and adaptable live-attenuated SARS-CoV-2 vaccine to reduce disease and transmission using one-to-stop genome modifications. Nature microbiology 9 (8) (2024)
Jacob Schön, Güliz Tuba Barut, Bettina Salome Trueeb, Nico Joël Halwe, Inês Berenguer Veiga, Annika Kratzel, Lorenz Ulrich, Jenna N Kelly, Melanie Brügger, Christoph Langner, Adriano Taddeo, Etori Aguiar Moreira, Demeter Túrós, Llorenç Grau-Roma, Ann Kathrin Ahrens, Kore Schlottau, Tobias Britzke, Angele Breithaupt, Björn Corleis, Jana Kochmann, Blandina I Oliveira Esteves, Lea Almeida, Lisa Thomann, Christelle Devisme, Hanspeter Stalder, Silvio Steiner, Sarah Ochsenbein, Kimberly Schmied, Fabien Labroussaa, Joerg Jores, Philip V'kovski, Vladimir Cmiljanovic, Marco P Alves, Charaf Benarafa, Nadine Ebert, Donata Hoffmann, Martin Beer, Volker Thiel
A safe, effective and adaptable live-attenuated SARS-CoV-2 vaccine to reduce disease and transmission using one-to-stop genome modifications. Nature microbiology 9 (8) (2024)
Güliz Tuba Barut, Nico Joël Halwe, Adriano Taddeo, Jenna N Kelly, Jacob Schön, Nadine Ebert, Lorenz Ulrich, Christelle Devisme, Silvio Steiner, Bettina Salome Trüeb, Martin Beer, Inês Berenguer Veiga, Nathan Georges François Leborgne, Etori Aguiar Moreira, Angele Breithaupt, Christoph Langner, Dirk Höper, Kerstin Wernike, Aurélie Godel, Lisa Thomann, Vera Flück, Hanspeter Stalder, Melanie Brügger, Blandina I Oliveira Esteves, Beatrice Zumkehr, Guillaume Beilleau, Annika Kratzel, Kimberly Schmied, Sarah Ochsenbein, Reto M Lang, Manon Wider, Carlos Machahua, Patrick Dorn, Thomas Michael Marti, Manuela Funke-Chambour, Andri Rauch, Marek Widera, Sandra Ciesek, Ronald Dijkman, Donata Hoffmann, Marco P Alves, Charaf Benarafa, Martin Beer, Volker Thiel
The spike gene is a major determinant for the SARS-CoV-2 Omicron-BA.1 phenotype. Nature communications 13 (1) (2022)
Melanie Brügger, Thomas Démoulins, Güliz Tuba Barut, Beatrice Zumkehr, Blandina I Oliveira Esteves, Kemal Mehinagic, Quentin Haas, Aline Schögler, Marie-Anne Rameix-Welti, Jean-François Eleouet, Ueli Moehrlen, Thomas M Marti, Ralph A Schmid, Artur Summerfield, Horst Posthaus, Nicolas Ruggli, Sean R R Hall, Marco P Alves
Pulmonary mesenchymal stem cells are engaged in distinct steps of host response to respiratory syncytial virus infection. PLoS pathogens 17 (7) (2021)
Thomas Démoulins, Melanie Brügger, Beatrice Zumkehr, Blandina I Oliveira Esteves, Kemal Mehinagic, Amal Fahmi, Loïc Borcard, Adriano Taddeo, Damian Jandrasits, Horst Posthaus, Charaf Benarafa, Nicolas Ruggli, Marco P Alves
The specific features of the developing T cell compartment of the neonatal lung are a determinant of respiratory syncytial virus immunopathogenesis. PLoS pathogens 17 (4) (2021)